Sign in

Kevin Shannon

About Kevin Shannon

Kevin Shannon (age 70) is an Independent Director of Morgan Stanley Direct Lending Fund (MSDL), serving since 2019 with his current Class I term expiring at the 2026 annual meeting . He was CFO of Harvard Management Company from 2009–2020, previously CFO/EVP at Moore Capital Management, senior finance roles at Lehman Brothers, and began as an auditor at KPMG; he holds a BS magna cum laude from NYU and an MBA from Fairleigh Dickinson University . He also serves on the boards of the other MS BDCs, has chaired valuation/risk committees in prior roles, and is active in community organizations and industry groups (Managed Funds Association) . The Board has determined he is an Independent Director under NYSE and 1940 Act standards and an “audit committee financial expert” .

Past Roles

OrganizationRoleTenureCommittees/Impact
Harvard Management Company, Inc.Chief Financial OfficerSep 2009–Apr 2020 Operating Committee (2009–2018), chaired Valuation Committee (Jun 2015–Dec 2017); oversaw Trust & Gifts Group since Dec 2016
Moore Capital Management, LLCCFO and Executive Vice President~15 years (prior to HMC) Board member, Risk Committee, Valuation Committee; responsible for treasury functions
Lehman BrothersSenior Vice President; CFO of derivatives products subsidiary; Director of Firm Trading Accounting & ControlsPrior to Moore Capital Finance, controls, derivatives oversight
KPMG LLPAuditor (financial services clients)Career start Audit practice
Baruch College (Dept. of Accounting)Adjunct lecturer (part-time)Two-year tenure Academic teaching

External Roles

OrganizationRoleTenureCommittees/Impact
Managed Funds AssociationDirector; Executive Committee Vice Chairman and TreasurerTwo consecutive terms (dates not specified) Executive Committee leadership
Efferent Health, LLC (private)Advisory Committee memberCurrent (date not specified) Advises medical imaging/data management venture
Help for ChildrenBoard member~20 years; board service ended Dec 31, 2023 Former Audit and Executive Committees
Boston Economics ClubMemberCurrent (date not specified) Professional network membership
MS BDCs in Fund Complex (T Series, PIF, PIF A, LGAM, SLIF)Director across MS BDCsSince formation (various dates) Oversees 6 portfolios in Fund Complex

Board Governance

  • Committee assignments and chairs:

    • Compensation Committee: Shannon is Chair; members include Binstock, Frank, Metz; all Independent under NYSE and 1940 Act .
    • Audit Committee: Member; all Independent under NYSE/Exchange Act; Board determined Shannon is an “audit committee financial expert” .
    • Nominating & Corporate Governance Committee: Member; all Independent; Chair is Binstock .
  • Independence and attendance:

    • Independent Director status affirmed after review of relationships under 1940 Act; Independent Directors comprise all committees .
    • Board met 5 times in 2024; no incumbent Director attended fewer than 75% of Board and relevant committee meetings; 2 Directors attended the 2024 annual meeting .
  • Lead Independent Director and executive sessions:

    • Company does not currently have a designated Lead Independent Director; offsets potential conflicts with regular executive sessions of Independent Directors and Independent-only committees .

Committee Meeting Activity

CommitteeFY 2023 MeetingsFY 2024 Meetings
Audit4 4
Compensation1 2
Nominating & Corporate Governance2 4

Fixed Compensation

  • Policy changes:
    • Pre-IPO (through Jan 26, 2024): Independent Directors received $75,000 annual fee; meeting fees ($2,000 per in-person Board, $1,000 telephonic; $1,000 per in-person committee, $500 telephonic, if not same day); Audit Chair received additional $7,500 .
    • Post-IPO (from Jan 26, 2024): Annual fee increased to $125,000; Audit Chair additional $15,000; reasonable out-of-pocket expenses reimbursed .
ComponentPre-IPOPost-IPO
Annual Director Fee (Cash)$75,000 $125,000
Audit Committee Chair Fee (Cash)$7,500 $15,000
Meeting FeesBoard: $2,000 in-person / $1,000 telephonic; Committee: $1,000 in-person / $500 telephonic (if not same day) Not specified post-IPO (policy highlights annual fee)
  • Actual compensation paid (Company and Fund Complex totals):
Metric202120232024
Total Compensation from Company (USD)$83,000 $75,000 $122,703
Total Compensation from Fund Complex (USD)$143,900 $276,164 $374,945

Note: Fund Complex includes MSDL, T Series, PIF, PIF A, LGAM, SL Investment Corp. and SLIF .

Performance Compensation

MetricStatus
Stock optionsNo awards granted in FY 2024; Item 402(x) not applicable
RSUs/PSUs (Director)No director equity awards disclosed; Independent Director compensation described as cash fees/retainers
Performance metrics tied to director compensationNone disclosed; Compensation Committee will not produce an executive compensation report because executives are not paid directly by the Company

Other Directorships & Interlocks

Company/EntityRoleInterlock/Relationship
Other MS BDCs (T Series, PIF, PIF A, LGAM, SLIF)DirectorShared adviser (Morgan Stanley IM) across Fund Complex; Shannon serves on all MS BDC boards since formation
Public/registered investment companies outside MS BDCsNone in past five yearsAs disclosed in director biography table
Efferent Health, LLCAdvisory Committee memberPrivate healthcare startup; advisory capacity
Managed Funds AssociationBoard and Exec Committee rolesIndustry association; prior leadership roles

Expertise & Qualifications

  • Audit committee financial expert designation under Item 407 of Regulation S‑K .
  • Senior finance leadership across endowment, hedge fund, and sell-side derivatives operations (HMC, Moore Capital, Lehman) .
  • Valuation and risk committee experience; treasury and control functions oversight .
  • Academic credentials: BS magna cum laude (NYU) and MBA (Fairleigh Dickinson) .

Equity Ownership

  • Beneficial ownership and alignment:
    • Shares beneficially owned as of the Record Date: 24,080; less than 1% of outstanding (87,920,526 shares) .
    • Prior year beneficial holdings: 24,079 (as of 2024 Record Date; 88,894,490 shares outstanding) .
    • Earlier holdings: 17,520.858 (as of 2022 Record Date; 57,196,918.324 shares outstanding) .
    • Dollar range ownership: “Over $100,000” in Company; “Over $100,000” aggregate in Fund Complex across years .
Metric202220242025
Shares Beneficially Owned17,520.858 24,079 24,080
% of Shares Outstanding<1% (57.2M SO) <1% (88.9M SO) <1% (87.9M SO)
Dollar Range – CompanyOver $100,000 Over $100,000 Over $100,000
Dollar Range – Fund ComplexOver $100,000 Over $100,000 Over $100,000
  • Hedging/pledging:
    • Code of Ethics does not expressly prohibit hedging transactions (e.g., collars, swaps, exchange funds) by directors or the Adviser’s personnel .
    • Pledging practices not disclosed .

Insider Trades (2025)

Filing DateTransaction DateTypeSharesPricePost-Transaction OwnershipSEC Link
2025-08-182025-08-14Open market purchase5,000$17.7029,079
2025-06-102025-06-06Open market purchase5,700 (indirect)$19.4255,700
2025-06-102025-06-06Open market purchase2,300 (indirect)$19.43972,300
2025-06-102025-06-06Open market purchase2,000 (indirect)$19.432,000

Governance Assessment

  • Board effectiveness and independence:

    • Shannon’s finance, valuation, and risk credentials strengthen audit oversight; designation as an audit committee financial expert and chairing the Compensation Committee since Sep 2023 indicate active, relevant governance engagement .
    • Attendance expectations met; no Director fell below 75%, and committee activity increased in 2024 (notably Nominating & Corporate Governance and Compensation) .
  • Alignment and incentives:

    • Compensation for Independent Directors is cash-based; post-IPO retainer increase to $125k with audit chair premium; no equity/option awards disclosed for directors—reduces dilution but can limit alignment versus equity-based plans .
    • Shannon holds >$100k in MSDL and made open market purchases in 2025, a positive alignment signal for investors .
  • Conflicts and related-party exposure:

    • External management via Morgan Stanley adviser; significant advisory/incentive fees paid (2024 base management fees $25.48M net of waiver; income-based incentive fees $37.43M); quarterly Audit Committee review of related-party transactions mitigates risks .
    • MS&Co underwriting IPO fees ($1.24M) and notes placement fees ($210,180) indicate affiliate transactions; board independence and oversight structures are important safeguards .
  • RED FLAGS

    • Hedging not explicitly prohibited in Code of Ethics could undermine ownership alignment if used; absence of disclosed stock ownership guidelines for directors is a governance gap .
    • No Lead Independent Director while an Interested Director chairs the Board increases perceived conflict risk; mitigations include independent-only committees and executive sessions but investors may prefer a lead independent role .

Overall, Shannon’s deep finance background, audit/valuation experience, and recent open market purchases support investor confidence, while structural conflicts inherent to externally managed BDCs and permissive hedging policy warrant close monitoring of committee governance and related-party oversight .